Gilead Sciences, Inc. (NASDAQ: GILD)
For nearly 2 months now, Gilead Sciences has been seeing tough times in the market. Sure, there were days here and there where uptrends would clear, but for the most part, we’ve seen losses. So, questions are starting to be asked about the stock. Questions like can GILD recover?
Yes GILD Will Recover!
I can’t tell the future, I have no crystal ball that gives me special powers, none of that! What I do have is data, and the data tells me that there are plenty of reasons for Gilead Sciences stock value to climb. Think about it…
- HIV – 35 million people around the world are affected by HIV; that’s huge. Do you know who the top treatment manufacturer is? Gilead Sciences!
- Hepatitis C – Between 130 and 150 million people globally are affected by hepatitis C. Another area where GILD treatments reign supreme.
Knowing the two tidbits of information above, how could Gilead Sciences not recover? They control two major markets by a landslide!
Is Now The Time To Buy?
In my personal opinion, I think that GILD is presenting a great opportunity to buy. The hits we’ve seen in the market have driven the price under $100 on a stock with an median price target of $120 and a bullish price target around $159.
What We’re Seeing Today
In morning trading we saw steep declines followed by level lows throughout the day. Currently (1:46), GILD is trading at $99.05 per share after losing 1.63% so far.
What Do You Think?
Where do you think GILD is headed and why? Let us know in the comments below!